0001863006 2022-06-30 0001863006 2021-12-31 0001863006 2022-01-01 2022-06-30 0001863006 2021-01-01 2021-06-30 0001863006 2022-04-01 2022-06-30 0001863006 2021-04-01 2021-06-30 0001863006 2020-12-31 0001863006 2022-03-31 0001863006 2021-03-31 0001863006 2021-06-30 0001863006 vln:NonExecutiveOfficersAndBoardMembersMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember vln:BoardMembersMember 2022-01-01 2022-06-30 0001863006 vln:BoardMembersMember us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2022-01-01 2022-06-30 0001863006 vln:BoardMembersMember us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2022-01-01 2022-06-30 0001863006 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001863006 vln:AudioVideoMember 2022-01-01 2022-06-30 0001863006 vln:AutomotiveMember 2022-01-01 2022-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2022-01-01 2022-06-30 0001863006 country:IL 2022-01-01 2022-06-30 0001863006 country:CN 2022-01-01 2022-06-30 0001863006 country:US 2022-01-01 2022-06-30 0001863006 country:HK 2022-01-01 2022-06-30 0001863006 country:JP 2022-01-01 2022-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-01-01 2022-06-30 0001863006 country:HU 2022-01-01 2022-06-30 0001863006 vln:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 vln:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 vln:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 vln:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 us-gaap:SalesRevenueNetMember vln:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 us-gaap:SalesRevenueNetMember vln:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 us-gaap:SalesRevenueNetMember vln:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceOneMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceTwoMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceThreeMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceFourMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceFiveMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceSixMember 2022-01-01 2022-06-30 0001863006 srt:MinimumMember 2022-01-01 2022-06-30 0001863006 srt:MaximumMember 2022-01-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001863006 srt:MinimumMember vln:ForfeitedSharesMember 2022-01-01 2022-06-30 0001863006 srt:MaximumMember vln:ForfeitedSharesMember 2022-01-01 2022-06-30 0001863006 us-gaap:ChangeDuringPeriodFairValueDisclosureMember vln:ForfeitedSharesMember 2022-01-01 2022-06-30 0001863006 vln:PtkSponsorMember 2022-01-01 2022-06-30 0001863006 vln:EqualToOrLessThanTwelveMonthMember 2022-01-01 2022-06-30 0001863006 vln:ValensSemiconductorLtdTwoThousandTwentyOneShareIncentivePlanMember 2022-01-01 2022-06-30 0001863006 vln:RelatedPartiesMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember vln:RelatedPartiesMember 2022-01-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001863006 vln:PrivateWarrantMember 2022-01-01 2022-06-30 0001863006 vln:PublicWarrantMember 2022-01-01 2022-06-30 0001863006 vln:ForfeiltureSharesMember 2022-01-01 2022-06-30 0001863006 vln:MonteCarloSimulationMember 2022-01-01 2022-06-30 0001863006 vln:ForfeitedOrdinarySharesMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceFourMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceThreeMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceTwoMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001863006 vln:RangeOfExercisePriceOneMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember vln:MergerAndAcquisitionTransactionMember 2022-01-01 2022-06-30 0001863006 srt:OfficeBuildingMember 2022-01-01 2022-06-30 0001863006 srt:OfficeBuildingMember country:IL 2022-01-01 2022-06-30 0001863006 us-gaap:VehiclesMember 2022-01-01 2022-06-30 0001863006 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001863006 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001863006 vln:AudioVideoMember 2021-01-01 2021-06-30 0001863006 vln:AutomotiveMember 2021-01-01 2021-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-06-30 0001863006 country:IL 2021-01-01 2021-06-30 0001863006 country:CN 2021-01-01 2021-06-30 0001863006 country:US 2021-01-01 2021-06-30 0001863006 country:HK 2021-01-01 2021-06-30 0001863006 country:JP 2021-01-01 2021-06-30 0001863006 vln:OtherGeographicalAreasMember 2021-01-01 2021-06-30 0001863006 country:HU 2021-01-01 2021-06-30 0001863006 vln:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 0001863006 vln:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 0001863006 vln:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 0001863006 vln:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 0001863006 vln:SeriesERedeemablePreferredStockMember 2021-01-01 2021-06-30 0001863006 vln:SeriesDRedeemablePreferredStockMember 2021-01-01 2021-06-30 0001863006 vln:SeriesCRedeemablePreferredStockMember 2021-01-01 2021-06-30 0001863006 vln:SeriesBTwoRedeemablePreferredStockMember 2021-01-01 2021-06-30 0001863006 vln:SeriesBOneRedeemablePreferredStockMember 2021-01-01 2021-06-30 0001863006 vln:SeriesARedeemablePreferredStockMember 2021-01-01 2021-06-30 0001863006 srt:MinimumMember 2021-01-01 2021-06-30 0001863006 srt:MaximumMember 2021-01-01 2021-06-30 0001863006 us-gaap:CostOfSalesMember 2021-01-01 2021-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001863006 vln:WarrantLiabilityMember 2021-01-01 2021-06-30 0001863006 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001863006 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001863006 vln:AudioVideoMember 2021-04-01 2021-06-30 0001863006 vln:AutomotiveMember 2021-04-01 2021-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2021-04-01 2021-06-30 0001863006 country:IL 2021-04-01 2021-06-30 0001863006 country:CN 2021-04-01 2021-06-30 0001863006 country:US 2021-04-01 2021-06-30 0001863006 country:HK 2021-04-01 2021-06-30 0001863006 country:JP 2021-04-01 2021-06-30 0001863006 vln:OtherGeographicalAreasMember 2021-04-01 2021-06-30 0001863006 country:HU 2021-04-01 2021-06-30 0001863006 vln:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001863006 vln:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001863006 vln:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001863006 vln:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001863006 vln:SeriesERedeemablePreferredStockMember 2021-04-01 2021-06-30 0001863006 vln:SeriesDRedeemablePreferredStockMember 2021-04-01 2021-06-30 0001863006 vln:SeriesCRedeemablePreferredStockMember 2021-04-01 2021-06-30 0001863006 vln:SeriesBTwoRedeemablePreferredStockMember 2021-04-01 2021-06-30 0001863006 vln:SeriesBOneRedeemablePreferredStockMember 2021-04-01 2021-06-30 0001863006 vln:SeriesARedeemablePreferredStockMember 2021-04-01 2021-06-30 0001863006 us-gaap:CostOfSalesMember 2021-04-01 2021-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2021-04-01 2021-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-04-01 2021-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2021-04-01 2021-06-30 0001863006 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001863006 vln:AudioVideoMember 2022-04-01 2022-06-30 0001863006 vln:AutomotiveMember 2022-04-01 2022-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2022-04-01 2022-06-30 0001863006 country:IL 2022-04-01 2022-06-30 0001863006 country:CN 2022-04-01 2022-06-30 0001863006 country:US 2022-04-01 2022-06-30 0001863006 country:HK 2022-04-01 2022-06-30 0001863006 country:JP 2022-04-01 2022-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-04-01 2022-06-30 0001863006 country:HU 2022-04-01 2022-06-30 0001863006 vln:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001863006 vln:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001863006 vln:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001863006 vln:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001863006 vln:PrivateWarrantMember 2022-04-01 2022-06-30 0001863006 vln:PublicWarrantMember 2022-04-01 2022-06-30 0001863006 vln:ForfeiltureSharesMember 2022-04-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001863006 vln:ForfeitureSharesMember 2022-06-30 0001863006 country:IL 2022-06-30 0001863006 country:TW 2022-06-30 0001863006 country:CN 2022-06-30 0001863006 country:US 2022-06-30 0001863006 vln:RangeOfExercisePriceOneMember 2022-06-30 0001863006 vln:RangeOfExercisePriceTwoMember 2022-06-30 0001863006 vln:RangeOfExercisePriceFiveMember 2022-06-30 0001863006 vln:RangeOfExercisePriceThreeMember 2022-06-30 0001863006 vln:RangeOfExercisePriceSixMember 2022-06-30 0001863006 vln:RangeOfExercisePriceFourMember 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 vln:ForfeitedSharesMember 2022-06-30 0001863006 vln:MonteCarloSimulationMember 2022-06-30 0001863006 vln:ValensSemiconductorLtdTwoThousandTwentyOneShareIncentivePlanMember 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember vln:MergerAndAcquisitionTransactionMember 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-06-30 0001863006 srt:MinimumMember vln:RangeOfExercisePriceOneMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 srt:MaximumMember vln:RangeOfExercisePriceOneMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 srt:MinimumMember vln:RangeOfExercisePriceTwoMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 srt:MaximumMember vln:RangeOfExercisePriceTwoMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 vln:RangeOfExercisePriceThreeMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 vln:RangeOfExercisePriceFourMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 vln:RangeOfExercisePriceOneMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 vln:RangeOfExercisePriceTwoMember us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001863006 srt:OfficeBuildingMember 2022-06-30 0001863006 us-gaap:VehiclesMember 2022-06-30 0001863006 vln:ForfeitureSharesMember 2021-12-31 0001863006 country:IL 2021-12-31 0001863006 country:TW 2021-12-31 0001863006 country:CN 2021-12-31 0001863006 country:US 2021-12-31 0001863006 vln:ForfeitedSharesMember 2021-12-31 0001863006 vln:ValensSemiconductorLtdTwoThousandTwentyOneShareIncentivePlanMember 2021-12-31 0001863006 vln:PipeFinancingMember vln:MergerAgreementClosingMember 2021-09-29 2021-09-29 0001863006 us-gaap:SalesRevenueNetMember vln:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001863006 us-gaap:SalesRevenueNetMember vln:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001863006 us-gaap:SalesRevenueNetMember vln:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001863006 vln:ForfeitedSharesMember srt:MinimumMember 2021-01-01 2021-12-31 0001863006 vln:ForfeitedSharesMember srt:MaximumMember 2021-01-01 2021-12-31 0001863006 vln:ForfeitedSharesMember us-gaap:ChangeDuringPeriodFairValueDisclosureMember 2021-01-01 2021-12-31 0001863006 us-gaap:AccountingStandardsUpdate201602Member 2022-01-01 0001863006 srt:MinimumMember 2022-06-30 2022-06-30 0001863006 srt:MaximumMember 2022-06-30 2022-06-30 0001863006 us-gaap:CommonStockMember 2021-12-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001863006 us-gaap:RetainedEarningsMember 2021-12-31 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001863006 vln:ForfeitedSharesMember us-gaap:ChangeDuringPeriodFairValueDisclosureMember 2021-12-31 0001863006 us-gaap:ChangeDuringPeriodFairValueDisclosureMember vln:ForfeitedSharesMember 2022-06-30 0001863006 us-gaap:CommonStockMember 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-06-30 0001863006 us-gaap:CommonStockMember 2020-12-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001863006 us-gaap:RetainedEarningsMember 2020-12-31 0001863006 us-gaap:CommonStockMember 2021-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001863006 us-gaap:RetainedEarningsMember 2021-06-30 0001863006 us-gaap:CommonStockMember 2021-03-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001863006 us-gaap:RetainedEarningsMember 2021-03-31 0001863006 us-gaap:CommonStockMember 2022-03-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001863006 us-gaap:RetainedEarningsMember 2022-03-31 0001863006 us-gaap:ChangeDuringPeriodFairValueDisclosureMember vln:ForfeitedSharesMember 2020-12-31 iso4217:USD xbrli:shares utr:Year xbrli:pure utr:Month utr:sqm iso4217:USD xbrli:shares vln:Quarters vln:Vehicles
Table of Contents
Exhibit 99.1
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
(Unaudited)
JUNE 30, 2022

Table of Contents
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
(Unaudited)
AS OF JUNE 30, 2022
CONTENTS
 
         
    
Page
 
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)-
IN U.S. DOLLARS ($):
        
   
     3-4  
     5  
     6  
     7  
     8-22  
 
 
 
 

Table of Contents
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
 
    
June 30,

2022
    
December 31,

2021
 
               
    
U.S. dollars in thousands
 
Assets
                 
     
CURRENT ASSETS:
                 
Cash and cash equivalents
     46,577        56,791  
Short-term deposits
     110,177        117,568  
Trade accounts receivable
     10,047        7,095  
Prepaid expenses
     3,584        6,927  
Other current assets
     908        1,328  
Inventories
     17,318        9,322  
    
 
 
    
 
 
 
TOTAL CURRENT ASSETS
     188,611        199,031  
     
LONG-TERM ASSETS:
                 
Property and equipment, net
     2,571        2,741  
Operating lease right-of-use assets
     4,408            
Other assets
     638        828  
    
 
 
    
 
 
 
TOTAL LONG-TERM ASSETS
     7,617        3,569  
    
 
 
    
 
 
 
TOTAL ASSETS
  
 
196,228
 
  
 
202,600
 
    
 
 
    
 
 
 
 
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
 
3

Table of Contents
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (continued)
 
 
    
June 30,

2022
   
December

31, 2021
 
              
    
U.S. dollars in thousands
 
Liabilities and Shareholders’ Equity
                
     
CURRENT LIABILITIES:
                
Trade accounts payable
     7,345       4,493  
Accrued compensation
     4,912       4,583  
Current maturities of operating leases liabilities
     1,814           
Other current liabilities
     6,257       6,623  
    
 
 
   
 
 
 
TOTAL CURRENT LIABILITIES
     20,328       15,699  
     
LONG-TERM LIABILITIES:
                
Forfeiture Shares, no par value: 1,006,250 shares authorized, issued and outstanding as of June 30, 2022 and December 31, 2021,respectively
     516       4,658  
Non-current operating leases liabilities
     2,126           
Other long-term liabilities
     48       46  
    
 
 
   
 
 
 
TOTAL LONG-TERM LIABILITIES
     2,690       4,704  
    
 
 
   
 
 
 
COMMITMENTS AND CONTINGENT LIABILITIES
            
TOTAL LIABILITIES
  
 
23,018
 
 
 
20,403
 
    
 
 
   
 
 
 
SHAREHOLDERS’ EQUITY:
                
Ordinary shares, no par value: 700,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 97,664,669, and 97,122,405 (excluding 1,006,250 ordinary shares subject to forfeiture) shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively.
     49       49  
Additional paid-in capital
     318,214       312,156  
Accumulated deficit
     (145,053     (130,008
    
 
 
   
 
 
 
TOTAL SHAREHOLDERS’ EQUITY
     173,210       182,197  
    
 
 
   
 
 
 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  
 
196,228
 
 
 
202,600
 
    
 
 
   
 
 
 
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
 
4

Table of Contents
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
 
    
Six months ended

June 30
   
Three months ended

June 30
 
    
2022
   
2021
   
2022
   
2021
 
                          
    
U.S. dollars in thousands, except share and

per share amounts
 
REVENUES
     44,101       30,874       22,481       17,510  
COST OF REVENUES
     (12,877     (8,875     (6,697     (5,043
    
 
 
   
 
 
   
 
 
   
 
 
 
GROSS PROFIT
     31,224       21,999       15,784       12,467  
         
OPERATING EXPENSES:
                                
Research and development expenses
     (29,031     (21,354     (14,904     (10,956
Sales and marketing expenses
     (8,682     (6,332     (4,473     (3,222
General and administrative expenses
     (8,641     (4,544     (4,340     (2,366
    
 
 
   
 
 
   
 
 
   
 
 
 
TOTAL OPERATING EXPENSES
     (46,354     (32,230     (23,717     (16,544
    
 
 
   
 
 
   
 
 
   
 
 
 
OPERATING LOSS
     (15,130     (10,231     (7,933     (4,077
Change in fair value of Forfeiture Shares
     4,142                1,538           
Financial income (expenses), net
     (3,675     336       (3,560     503  
    
 
 
   
 
 
   
 
 
   
 
 
 
LOSS BEFORE INCOME TAXES
     (14,663     (9,895     (9,955     (3,574
INCOME TAXES
     (389     (179     (43     (124
    
 
 
   
 
 
   
 
 
   
 
 
 
LOSS AFTER INCOME TAXES
     (15,052     (10,074     (9,998     (3,698
Equity in earnings of investee
     7                3           
    
 
 
   
 
 
   
 
 
   
 
 
 
NET LOSS
     (15,045     (10,074     (9,995     (3,698
    
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net loss per ordinary share
     (0.15     (1.61     (0.10     (0.68
    
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average number of shares used in computing net loss per ordinary share
     97,296,206       10,927,357       97,442,359       11,020,299  
    
 
 
   
 
 
   
 
 
   
 
 
 
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
 
5

Table of Contents
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (Unaudited)
 
    
Six months ended June 30, 2022
 
    
Ordinary shares
    
Additional

paid-

in capital
    
Accumulated

deficit
   
Total
 
    
Shares
    
Amount
 
Balance - January 1, 2022
     97,122,405        49        312,156        (130,008     182,197  
Exercise of options and RSUs
     542,264                  150        —         150  
Stock based compensation
     —          —          5,908        —         5,908  
Net loss for the period
     —          —          —          (15,045     (15,045
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance – June 30, 2022
     97,664,669        49        318,214        (145,053     173,210  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
   
    
Six months ended June 30, 2021
 
    
Ordinary shares
    
Additional

paid-

in capital
    
Accumulated

deficit
   
Total
 
    
Shares
    
Amount
 
Balance - January 1, 2021
     10,795,372        40        21,211        (103,474     (82,223
Exercise of options
     954,183        4        661        —         665  
Stock based compensation
     —          —          3,290        —         3,290  
Net loss for the period
     —          —          —          (10,074     (10,074
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance – June 30, 2021
     11,749,555        44        25,162        (113,548     (88,342
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
   
    
Three months ended June 30, 2022
 
    
Ordinary shares
    
Additional
paid-

in capital
    
Accumulated

deficit
   
Total
 
    
Shares
    
Amount
 
Balance - April 1, 2022
     97,191,467        49        315,001        (135,058     179,992  
Exercise of options and RSUs
     473,202                  96        —         96  
Stock based compensation
     —          —          3,117        —         3,117  
Net loss for the period
     —          —          —          (9,995     (9,995
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance - June 30, 2022
     97,664,669        49        318,214        (145,053     173,210  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
   
    
Three months ended June 30, 2021
 
    
Ordinary shares
    
Additional

paid-

in capital
    
Accumulated

deficit
   
Total
 
    
Shares
    
Amount
 
Balance - April 1, 2021
     10,912,912        41        22,881        (109,850     (86,928
Exercise of options
     836,643        3        586        —         589  
Stock based compensation
     —          —          1,695        —         1,695  
Net loss for the period
     —          —          —          (3,698     (3,698
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance - June 30, 2021
     11,749,555        44        25,162        (113,548     (88,342
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
 
6

Table of Contents
VALENS SEMICONDUCTOR LTD.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
 
    
Six months ended

June 30
   
Three months ended

June 30
 
    
2022
   
2021
   
2022
   
2021
 
                          
    
U.S. dollars in thousands
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                                
Net loss for the period
     (15,045     (10,074     (9,995     (3,698
Adjustments to reconcile net loss to net cash used in operating activities:
                                
Income and expense items not involving cash flows:
                                
Depreciation
     667       522       347       266  
Stock-based compensation
     5,908       3,290       3,117       1,695  
Exchange rate differences
     4,972       (231     4,501       (545
Interest from short-term deposits
     (295     219       (132     37  
Change in fair value of Forfeiture Shares
     (4,142              (1,538         
Reduction in the carrying amount of ROU assets
     844                424           
Changes in operating assets and liabilities:
                                
Trade accounts receivable
     (2,952     767       166       (2,475
Prepaid expenses
     3,343       (1,833     3,051       (599
Other current assets
     420       245       194       141  
Inventories
     (7,996     (2,541     (4,852     (1,752
Other assets
     190       (31     86       (26
Trade accounts payable
     2,779       1,124       1,691       451  
Accrued compensation
     329       (948     508       107  
Other current liabilities
     (366     (153     (1,010     (45
Change in operating lease liabilities
     (1,312              (811         
Other long-term liabilities
     2       (7     2           
    
 
 
   
 
 
   
 
 
   
 
 
 
Net cash used in operating activities
     (12,654     (9,651     (4,251     (6,443
         
CASH FLOWS FROM INVESTING ACTIVITIES:
                                
Investment in short-term deposits
     (31,340     (4,520     (13,088     (4,520
Maturities of short-term deposits
     37,400       29,500       21,900       12,500  
Purchase of property and equipment
     (424     (505     (244     (127
    
 
 
   
 
 
   
 
 
   
 
 
 
Net cash provided by investing activities
     5,636       24,475       8,568       7,853  
         
CASH FLOWS FROM FINANCING ACTIVITIES:
                                
Deferred issuance costs
              (218              (218
Exercise of options
     150       665       96       589  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net cash provided by financing activities
     150       447       96       371  
         
Effect of exchange rate changes on cash and cash equivalents
     (3,346     217       (2,830     531  
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
  
 
(10,214
 
 
15,488
 
 
 
1,583
 
 
 
2,312
 
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD
  
 
56,791
 
 
 
26,316
 
 
 
44,994
 
 
 
39,492
 
    
 
 
   
 
 
   
 
 
   
 
 
 
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD
  
 
46,577
 
 
 
41,804
 
 
 
46,577
 
 
 
41,804
 
    
 
 
   
 
 
   
 
 
   
 
 
 
SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION -
                                
Cash paid for taxes
     121       224       65       147  
    
 
 
   
 
 
   
 
 
   
 
 
 
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
                                
Trade accounts payable on account on property and equipment
     73                             
Unpaid issuance costs
              2,722                2,722  
Operating lease liabilities arising from obtaining operating right-of-use assets
     350                104           
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
 
7

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
NOTE 1 - GENERAL:
 
 
a.
Valens Semiconductor Ltd. (hereafter “Valens”, and together with its wholly owned subsidiaries, the “Company”), was incorporated in Israel in 2006.
Valens is a leading provider of semiconductor products (chips), operates in the Audio-Video and Automotive industries, renowned for its Physical Layer (PHY) technology, enabling resilient high-speed connectivity over simple, low-cost infrastructure. Valens is the inventor of the HDBaseT Technology, which enables the converged delivery of ultra-high-definition digital video and audio, Ethernet, control signals, USB and power through a single cable. In the audio-video space, Valens’ HDBaseT technology enables plug-and-play digital connectivity between ultra-HD video sources and remote displays. In the automotive domain, Valens’ product offering includes both symmetric and asymmetric connectivity technology for high bandwidth transmission of native interfaces over a single low-cost wires and connectors. Valens’ advanced PHY technology for the auto industry provides the safety and resilience required to handle the noisy automotive environment, addressing the needs of Advanced Driver Assistance Systems (ADAS), Automotive Data Solutions (ADS), infotainment, telematics and backbone connectivity.
 
 
b.
On March 11, 2020, the World Health Organization designated the outbreak of a novel strain of coronavirus (“COVID-19”) as a global pandemic. Governments and businesses around the world have taken unprecedented actions to mitigate the spread of COVID-19, including imposing restrictions on movement and travel such as quarantines and shelter-in-place requirements, and restricting or prohibiting outright some or all commercial and business activity. These measures, though currently temporary in nature, may become more severe and continue indefinitely depending on the evolution of the COVID-19 pandemic. Although there are effective vaccines for COVID-19 that have been approved for use, not all the Company’s employees are vaccinated and specifically not with the booster vaccination. In addition, new strains of the virus have appeared (primarily, and most recently the Omicron variant), which may complicate treatment and vaccination programs. Accordingly, concerns remain regarding additional surges of the pandemic or the expansion of the economic impact thereof, and the extent to which the COVID-19 pandemic may impact the Company’s future results of operations and financial condition.
The Company has taken precautionary measures intended to help minimize the risk of the virus to its employees, including requiring some of the employees to work remotely and suspended all non-essential travels.
The Company’s business and operations have been and could in the future be adversely affected by the global COVID-19 pandemic. The COVID-19 pandemic and efforts to control its spread have curtailed the movement of people, goods and services worldwide, including in the regions in which we and our customers and partners operate, and are significantly impacting economic activity and financial markets. During 2020, 2021 and for the six months ended on June 30, 2022, the Company noticed a negative impact from COVID-19 on some of its customers’ demand, particularly with respect to end users’ audio-video and multimedia products that are used in public areas and for public events. Yet, the Company did receive an increase in demand for its high-speed connectivity products driven by a need for products and infrastructure to support the world’s developed trends derived from COVID-19 such as working from home, hybrid educational models and remote healthcare. On the product supply side, as the shortage in the semiconductor industry increases, the Company continues to face the impact of extended lead times from its suppliers as well as cost increases for certain raw materials that are in short supply, which may impact the Company’s revenues and gross margins.
Overall, considering the changing nature and continuing uncertainty around the COVID-19 pandemic, the Company’s ability to predict the impact of COVID-19 on its business in future periods remains limited. The effects of the pandemic on the Company’s business is unlikely to be fully realized, or reflected in its financial results, until future periods.
 
8

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 1 - GENERAL
(continued)
:
 
 
c.
On September 29, 2021 (the “Closing Date”), the Company consummated a merger transaction (referred to as the “Merger Agreement Closing”) pursuant to a merger agreement, dated May 25, 2021 (the “Merger Agreement”), by and among the Company, PTK Acquisition Corp. (“PTK”), a Delaware corporation whose common stock and warrants were then traded on the New York Stock Exchange and Valens Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company.
As a result of the Merger Agreement Closing, and upon consummation of other transactions contemplated by the Merger Agreement Closing (the “Transactions”), including the execution of series of subscription agreements, providing for the purchase of Valens Ordinary Shares by certain PIPE Investors (the “PIPE Financing”) at the Closing Date, as of September 30, 2021, the Company began trading on the New York Stock Exchange under the Symbol “VLN”.
The net proceeds received by the Company as part of the Merger Agreement Closing and the PIPE Financing totaled to $131.6 million.
Please also refer to Note 1(d) in the consolidated financial statement for the year ended December 31, 2021.
 
 
d.
Military Tensions Between Russia and Ukraine
In February 2022, Russian forces launched a military invasion of Ukraine. In response, the United States, the European Union, United Kingdom and other governments have imposed significant economic sanctions on Russia, and Russia has responded with counter-sanctions. The war in Ukraine has disrupted international commerce and the global economy.
Although the Company does not currently operate in Ukraine or Russia and therefore does not experience any impact from the war in Ukraine, the duration and severity of the effects on its busines and the global economy are inherently unpredictable. Management will continue to monitor the effects of the war in Ukraine and its potential further impacts on the Company.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
 
 
a.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting.
Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In our opinion, the information contained herein reflects all adjustments necessary for a fair statement of our results of operations, financial position, cash flows, and shareholders’ equity. All such adjustments are of a normal, recurring nature.
The results of operations for the six and three months ended June 30, 2022 shown in this report are not necessarily indicative of the results to be expected for the full year ending December 31, 2022. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2021 as filed in the Company’s 20-F.
 
9

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(continued)
:
 
There have been no material changes in our significant accounting policies as described in our consolidated financial statements for the year ended December 31, 2021, other than as stated below.
 
 
b.
Lease
On January 1, 2021 the Company adopted ASU No. 2016-02, Leases (“Topic 842”), The Company determines if an arrangement is a lease at inception. Balances related to operating leases are included in operating lease right-of-use (“ROU”) assets, Current maturities of operating leases liabilities and Non-current operating leases liabilities in the consolidated balance sheets.
The Company also elected
not
separating lease components from non-lease components and to keep leases with an initial term of 12 months or less off the balance sheet and recognize the associated lease payments in the consolidated statements of operations on a straight-line basis over the lease term.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized as of the commencement date based on the present value of lease payments over the lease term. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate for the lease is the rate implicit in the lease unless that rate cannot be readily determined. As the Company’s leases do not provide an implicit rate, the Company’s uses its estimated incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term (see also note 4).
 
 
c.
New Accounting Pronouncements
Recently Adopted accounting Standards:
In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASC 842”), on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 provides a number of optional practical expedients in transition, which permits the Company not to reassess its prior conclusions regarding lease identification, lease classification and initial direct costs under the new standard. The guidance is effective for the Company for annual periods beginning after December 15, 2021 and interim periods within annual periods beginning after December 15, 2022. The Company adopted ASC 842 on January 1, 2022, using a modified retrospective transition approach, at the effective date, without adjusting the comparative periods. The Company elected to utilize the available package of practical expedients permitted under the transition guidance within ASC 842 which does not require it to reassess the prior conclusions about lease identification, lease classification and initial direct costs.
 
10

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 2   -   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(continued)
:
 
Upon adoption of ASC 842, the Company recognized operating right-of-use assets of $4.9 million with corresponding operating lease liabilities on its consolidated balance sheet as of January 1, 2022. See Note 4 for further details.
Recently issued accounting pronouncements, not yet adopted:
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (“ASC 326”): Measurement of Credit Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. ASU No. 2016-13 is effective for the Company for the annual period beginning after December 15, 2022, including interim periods within that reporting period. The Company is currently evaluating the impact of adoption of the new standard on its consolidated financial statements.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (“Topic 740”): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU No. 2019-12 is effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements.
NOTE 3 – INVENTORIES:
 
    
June 30,

2022
    
December 31,

2021
 
               
    
U.S. dollars in thousands
 
Work in process
     8,056        4,718  
Finished goods
     9,262        4,604  
    
 
 
    
 
 
 
       17,318        9,322  
    
 
 
    
 
 
 
NOTE 4 - LEASES:
As of June 30, 2022, the Company has several operating lease agreements for its facilities and vehicles as follows:
Offices:
The Company’s corporate headquarters are located in Hod Hasharon, Israel, consisting of approximately 5,500 square meters of facility space under lease that will expire on February 28, 2023, with an option to extend the lease period by additional two years until February 28, 2025. The Company concluded that it is reasonably certain that it will exercise the renewal option. Accordingly, such renewal option was included in determining the lease term.
The monthly rent payment is approximately $132 thousands.
The Company has entered into various operating leases for office buildings in other territories. The total monthly rent payment of those leases is approximately $10 thousands.
 
11

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 4 - LEASES
(continued):
 
Vehicles:
The Company rents motor vehicles for use by some of its employees under operating lease agreements with lease terms of three years. As collateral for the cars’ lease agreements, the Company pays in advance the fee for the last month under the lease agreement.
As of June 30, 2022, the Company is engaged with car lease companies for leasing of over 30 vehicles. The monthly payments for those agreements are approximately $27 thousands.
The table below presents the effects on the amounts relating to the Company’s total lease costs:
 
    
For the six

months ended

on June

30,2022
    
For the three

months ended

on June 30,

2022
 
               
    
U.S. dollars in thousands
 
Operating lease cost:
                 
Fixed Payment
     1,184        585  
The table below presents supplemental cash flow information related to operating leases:​​​​​​​
 
    
For the six

months ended

on June

30,2022
    
For the three

months ended

on June

30,2022
 
               
    
U.S. dollars in thousands
 
Cash paid for amounts included in the measurement of lease liabilities:
                 
Operating cash flows for operating leases
     1,066        509  
     
Right-of-use assets obtained in exchange for lease obligations (non-cash):
                 
Operating leases, for initial adoption refer to note 2(c)
     350        104  
The table below presents supplemental balance sheet information related to operating leases:
 
    
June 30, 2022
 
    
U.S. dollars in

thousands
 
Operating lease right-of-use assets
     4,408  
    
 
 
 
Current maturities of operating leases
     1,814  
Non-current operating leases
     2,126  
    
 
 
 
Total operating lease liabilities
     3,940  
    
 
 
 
Weighted average remaining lease term (years)
     2.5  
    
 
 
 
Weighted annual average discount rate
     13.06
    
 
 
 
 
12

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 4 - LEASES
(continued):
The table below presents maturities of operating lease liabilities:
 
    
June 30, 2022
 
    
U.S. dollars in
thousands
 
2022
     1004  
2023
     1,863  
2024
     1,722  
2025
     26  
    
 
 
 
Total operating lease payments
     4,615  
    
 
 
 
Less: imputed interest
     (675
    
 
 
 
Present value of lease liabilities
     3,940  
    
 
 
 
NOTE 5 - COMMITMENTS AND CONTINGENT LIABILITIES:
 
 
a.
Noncancelable Purchase Obligations
The Company depends upon third party subcontractors for manufacturing of wafers, packaging and final tests. As of June 30, 2022, and December 31, 2021, the total value of open purchase orders for such manufacturing contractors was approximately $27,563 thousand and $50,591 thousand, respectively.
The Company has noncancelable purchase agreements for certain IP embedded in the Company products as well as certain agreement for the license of development tools used by the development team. As of June 30, 2022, and December 31, 2021, the total value of non-paid amounts related to such agreements totaled $4,557 thousand and $6,563 thousand, respectively.
 
 
b.
Legal proceedings
As of June 30, 2022, and to date, the Company is not a party to, or subject to the provisions of any order, writ, injunction, judgment or decree of any court or governmental agency or instrumentality. There is
no
action, suit, proceeding or investigation by the Company currently pending or that the Company intends to initiate.
NOTE 6 - OTHER CURRENT LIABILITIES:
 
    
June 30,

2022
    
December 31,

2021
 
               
    
U.S. dollars in thousands
 
Accrued vacation
     3,566        3,464  
Taxes payable
     36        40  
Accrued expenses- related party
     142        142  
Accrued expenses
     2,513        2,977  
    
 
 
    
 
 
 
       6,257        6,623  
    
 
 
    
 
 
 
 
13

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 7 - FORFEITURE SHARES:
 
 
a.
On the Closing Date, 1,006,250 Ordinary Shares that PTK sponsor received in respect of its PTK common stock, are subject to forfeiture if certain price targets for the Valens Ordinary Shares are not achieved within a certain period of time (of up to four years), after the Closing Date or if an M&A Transaction (as defined in the Merger Agreement Closing), does not occur at a certain minimum price.
The Company performed a Monte-Carlo simulation to calculate the fair value of such shares. As of the Closing Date, the fair value was $4,485 using the following assumptions: stock price of $7.4, expected term of 3-4 years, expected volatility of 47.74%-50.31% and risk-free interest rate of return of 0.53%-0.76%.
The fair value of the Forfeiture Shares was computed using the following key assumptions:
 
    
June 30, 2022
  
December 31, 2021
           
Stock price
   3.5    7.7
Expected term (years)
   2.25-3.25    2.75-3.75
Expected volatility
  
48.35%-49.27%
  
48.77%-48.92%
Risk-free interest rate
   2.94%-2.99%    0.91%-1.08%
 
 
b.
The table below sets forth a summary of the changes in the fair value of the Forfeiture Shares classified as Level 3:
 
    
Six months

ended

June 30,

2022
    
Year

ended

December

31, 2021
 
               
    
U.S. dollars in

thousands
 
Balance at beginning of period
     4,658            
Issuance of Forfeiture Shares
               4,485  
Changes in fair value
     (4,142      173  
    
 
 
    
 
 
 
Balance at end of the period
     516        4,658  
    
 
 
    
 
 
 
NOTE 8 - STOCK-BASED COMPENSATION:
Stock Options
The Company’s stock options have a term of up to 10 years from grant date unless extended by the Board of Directors. The granted options generally vest as follows: 25% on the first anniversary from the “Vesting Start Date” as defined in the grant agreement and remainder vest ratably over the following 12 quarters.
As of June 30, 2022, and December 31, 2021, the number of ordinary shares included in the Company’s option plans totaled to 28,383,788.
1,884,933 out of the outstanding options that have not yet vested as of June 30, 2022, have acceleration mechanisms according to certain terms set forth in the grant agreements primarily in the case of an M&A Transaction which constitutes a Liquidation Event (as defined in Note 9 in the consolidated financial statement for the year ended December 31, 2021).
As of June 30, 2022, the unrecognized compensation costs related to those unvested stock options are $5,899 thousand, which are expected to be recognized over a weighted-average period of 1.87 years.
 
14

Table of Contents
The following is a summary of the status of the Company’s share option plan as of June 30, 2022, as well as changes during the period of six months ended June 30,2022:
 
    
Six months ended

June 30, 2022
 
    
Number of

Options
    
Weighted-

Average

Exercise price
 
               
Options outstanding as of December 31, 2021
     15,449,513      $ 0.73  
Granted during the period
     239,610      $ 6.28  
Exercised during the period
     (512,357    $ 0.30  
Forfeited during the period
     (38,017    $ 0.86  
    
 
 
          
Options outstanding as of June 30, 2022
     15,138,749      $ 0.83  
    
 
 
          
Options exercisable as of June 30, 2022
     11,985,418      $ 0.72  
    
 
 
          
The following table summarizes information about stock options outstanding as of June 30, 2022:
 
Outstanding as of June 30, 2022
    
Exercisable as of June 30, 2022
 
Range of

exercise

prices
    
Number

outstanding
    
Weighted

average

remaining

contractual

term
    
Weighted

average

exercise

price
    
Aggregate

intrinsic

value (U.S.

dollars in

thousands)
    
Number

Exercisable
    
Weighted

average

remaining

contractual

term
    
Weighted

Average

exercise

price
    
Aggregate

intrinsic

value (U.S.

dollars in

thousands)
 
                                                           
 
$0.15-$0.86
       14,852,976        5.79      $ 0.73        40,785        11,923,755        5.25      $ 0.70        33,112  
  $1.87        5,963        8.53      $ 1.87        10        1,863        8.53      $ 1.87        3  
  $2.10        33,126        2.20      $ 2.10        46        33,126        2.20      $ 2.10        46  
  $5.36        140,000        7.00      $ 5.36        —          —          —          —          —    
  $7.58        99,610        6.55      $ 7.58        —          24,906        6.55      $ 7.58        —    
  $9.07        7,074        9.46      $ 9.07        —          1,768        9.46      $ 9.07        —    
The calculated fair value of option grants was estimated using the Black-Scholes option-pricing model with the following assumptions:
 
    
For the Six

months ended

on June

30,2022
 
For the six

months

ended on

June 30 2021
          
Expected term
   6-10   6-10
Expected volatility
  
46.73%-47.71%
 
48.15%-50.7%
Expected dividend rate
   0%   0%
Risk-free rate
   1.37%-3.00%  
0.61%-1.74%
During the six months period ended on June 30, 2022, 239,610 options were granted to related parties (please refer to Note 12 for further information).
As of June 30, 2022, the unrecognized compensation costs related to unvested stock options was $11,252 thousand, which are expected to be recognized over a weighted-average period of 2.27 years.
 
15

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 8 - STOCK-BASED COMPENSATION
(continued):
 
The following table presents the classification of the stock options expenses for the periods indicated:
 
    
Six months ended

June 30
    
Three months ended

June 30
 
    
2022
    
2021
    
2022
    
2021
 
                             
    
U.S. dollars in thousands
 
Cost of revenue
     114        47        60        (10
Research and development
     907        755        456        374  
Selling, general and administrative
     2,059        2,488        1,044        1,331  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation
  
 
3,080
 
  
 
3,290
 
  
 
1,560
 
  
 
1,695
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Restricted Stock Units
The following is a summary of the status of the Company’s RSU’s as of June 30, 2022, as well as changes during the period of six months ended June 30, 2022:
 
    
Six months ended

June 30, 2022
 
    
Number of

RSUs
    
Weighted-

Average Grant

Date Fair Value
 
RSUs outstanding at the beginning of the year
     133,384      $ 7.89  
Granted during the period
     3,699,376      $ 6.24  
Exercised during the period
     (29,907    $ 6.79  
Forfeited during the period
     (62,986    $ 6.43  
    
 
 
          
Outstanding at the end of the period
     3,739,867      $ 6.29  
    
 
 
          
RSUs exercisable at June 30, 2022
                  
    
 
 
          
The following table summarizes information about outstanding RSU’s as of June 30, 2022:
 
Outstanding as of June 30, 2022
    
Exercisable as of June 30, 2022
 
Range of

exercise

prices
    
Number
outstanding
    
Weighted
average

remaining

contractual

term
    
Weighted

average

exercise

price
    
Aggregate

intrinsic value

(U.S. dollars

in thousands)
    
Number

Exercisable
    
Weighted

average

remaining

contractual

term
    
Weighted

Average

exercise

price
    
Aggregate

intrinsic

value (U.S.

dollars in

thousands)
 
 
$3.31-$3.47
       240,000        6.94      $ 3.40      $ 833        —          —          —          —    
 
$6.41-$6.43
       3,302,159        6.81      $ 6.43      $ 11,491        —          —          —          —    
  $6.80        66,174        6.55      $ 6.80      $ 230        —          —          —          —    
  $7.89        131,534        6.46      $ 7.89      $ 458        —          —          —          —    
As of June 30, 2022, the unrecognized compensation cost related to unvested RSUs totaled to approximately $19,124 thousand and is expected to be expensed over a weighted-average recognition period of approximately 3.5 years.
During the six months ended on June 30, 2022 491,775 RSU’s were granted to several related parties (please refer to Note 12 regarding Related Parties).
 
16

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 8 - STOCK-BASED COMPENSATION
(continued)
:
 
The following table presents the classification of RSU’s expenses for the periods indicated:
 
    
Six months ended

June 30
    
Three months ended

June 30
 
    
2022
    
2021
    
2022
    
2021
 
                             
    
U.S. dollars in thousands
 
Cost of revenue
     155        —          84        —    
Research and development
     1,467        —          809        —    
Selling, general and administrative
     1,206        —          664        —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation- RSUs
  
 
2,828
 
  
 
—  
 
  
 
1,557
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
NOTE 9 - NET INCOME (LOSS) PER ORDINARY SHARE:
The following table sets forth the computation of basic and diluted net income (loss) per ordinary share for the periods indicated:
 
    
Six months ended
    
Three months ended
 
    
June 30,

2022
    
June 30,

2021
    
June 30,

2022
    
June 30,

2021
 
                             
Basic net loss per ordinary share
                                   
Numerator:
                                   
Net loss from continuing operations
     (15,045      (10,074      (9,995      (3,698
Dividend on Series E Redeemable Preferred
     —          (1,788      —          (906
Dividend on Series D Redeemable Preferred
     —          (2,654      —          (1,346
Dividend on Series C Redeemable Preferred
     —          (941      —          (477
Dividend on Series B-2 Redeemable Preferred
     —          (650      —          (329
Dividend on Series B-1 Redeemable Preferred
     —          (262      —          (129
Dividend on Series A Redeemable Preferred
     —          (1,183      —          (601
    
 
 
    
 
 
    
 
 
    
 
 
 
Numerator for basic and diluted net loss per common share – net loss attributable to common stockholders
     (15,045      (17,552      (9,995      (7,486
    
 
 
    
 
 
    
 
 
    
 
 
 
Denominator:
                                   
Denominator for basic and dilutive net loss per common share- adjusted weighted-average share
     97,296,206        10,927,357        97,442,359        11,020,299  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and dilutive net loss per common share
     (0.15      (1.61      (0.10      (0.68
    
 
 
    
 
 
    
 
 
    
 
 
 
 
17

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
The following weighted-average shares of securities were not included in the computation of diluted net income (loss) per common share as their effect would have been antidilutive:
 
    
Six months ended
    
Three months ended
 
    
June 30,

2022
    
June 30,

2021
    
June 30,

2022
    
June 30,

2021
 
                             
Options
     15,378,561        16,408,933        15,300,870        16,432,641  
Restricted Stock Units
     2,748,135        —          3,649,756        —    
Warrants liability
     —          40,452        —          —    
Private Warrants
     3,330,000        —          3,330,000        —    
Public Warrants
     5,750,000        —          5,750,000        —    
Forfeiture Shares
     1,006,250        —          1,006,250        —    
Redeemable convertible Preferred A shares
     —          32,901,384        —          32,901,384  
Redeemable convertible Preferred B-1 shares
     —          10,078,756        —          10,119,208  
Redeemable convertible Preferred B-2 shares
     —          18,670,270        —          18,670,270  
Redeemable convertible Preferred C shares
     —          9,424,938        —          9,424,938  
Redeemable convertible Preferred D shares
     —          19,313,646        —          19,313,646  
Redeemable convertible Preferred E shares
     —          11,080,674        —          11,080,674  
NOTE 10 - FINANCIAL INCOME, NET:
 
    
Six months ended

June 30
    
Three months ended

June 30
 
    
2022
    
2021
    
2022
    
2021
 
                             
    
U.S. dollars in thousands
 
Foreign currency exchange differences
     (3,865      239        (3,554      474  
Interest income on short-term deposits
     404        112        199        37  
Other
     (214      (15      (205      (8
    
 
 
    
 
 
    
 
 
    
 
 
 
Total financial income (expenses), net
  
 
(3,675
  
 
336
 
  
 
(3,560
  
 
503
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
18

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 11 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER:
 
 
a.
For the purpose of evaluating financial performance and allocating resources, the CODM reviews financial information presented on a consolidated basis accompanied by disaggregated information about revenues, gross profit and operating loss by the two identified reportable segments, to make decisions about resources to be allocated to the segments and assess their performance. Assets information is not provided to the CODM and is not being reviewed. Revenues and cost of goods sold are directly associated with the activities of a specific segment. Direct operating expenses, including general and administrative expenses, associated with the activities of a specific segment are charged to that segment. General and administrative expenses which cannot be attributed directly, are allocated evenly between segments. Other operating expenses are allocated to segments based on headcount ratio.​​​​​​​
 
    
Six months ended on June 30, 2022
 
    
Audio-

Video
    
Automotive
    
Consolidated
 
                      
    
U.S. dollars in thousands
 
Revenues
     35,067        9,034        44,101  
Gross profit
     27,881        3,343        31,224  
Research and development expenses
     11,392        17,639        29,031  
Sales and marketing expenses
     3,695        4,987        8,682  
General and administrative expenses
     4,244        4,397        8,641  
    
 
 
    
 
 
    
 
 
 
Segment operating profit (loss)
     8,550        (23,680      (15,130
    
 
 
    
 
 
    
 
 
 
Change in fair value of Forfeiture Shares
                       4,142  
Financial expenses, net
                       (3,675
                      
 
 
 
Loss before taxes on income
                       (14,663
                      
 
 
 
Depreciation expenses
     303        364        667  
    
 
 
    
 
 
    
 
 
 
   
    
Six months ended on June 30, 2021
 
    
Audio-

Video
    
Automotive
    
Consolidated
 
                      
    
U.S. dollars in thousands
 
Revenues
     27,145        3,729        30,874  
Gross profit
     21,266        733        21,999  
Research and development expenses
     5,255        16,099        21,354  
Sales and marketing expenses
     3,437        2,895        6,331  
General and administrative expenses
     2,303        2,241        4,544  
    
 
 
    
 
 
    
 
 
 
Segment operating profit (loss)
     10,271        (20,502      (10,231
    
 
 
    
 
 
    
 
 
 
Financial expenses, net
                       336  
                      
 
 
 
Loss before taxes on income
                       (9,895
                      
 
 
 
Depreciation expenses
     171        351        522  
    
 
 
    
 
 
    
 
 
 
 
19

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 11 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER
(continued)
:
 
    
Three months ended on June 30, 2022
 
    
Audio-

Video
    
Automotive
    
Consolidated
 
                      
    
U.S. dollars in thousands
 
Revenues
     18,335        4,146        22,481  
Gross profit
     14,414        1,370        15,784  
Research and development expenses
     5,122        9,782        14,904  
Sales and marketing expenses
     1,917        2,556        4,473  
General and administrative expenses
     2,081        2,259        4,340  
    
 
 
    
 
 
    
 
 
 
Segment operating profit (loss)
     5,294        (13,227      (7,933
    
 
 
    
 
 
    
 
 
 
Change in fair value of Forfeiture Shares
                       1,538  
Financial expenses, net
                       (3,560
                      
 
 
 
Loss before taxes on income
                       (9,955
                      
 
 
 
Depreciation expenses
     161        186        347  
    
 
 
    
 
 
    
 
 
 
   
    
Three months ended on June 30, 2021
 
    
Audio-

Video
    
Automotive
    
Consolidated
 
                      
    
U.S. dollars in thousands
 
Revenues
     15,513        1,997        17,510  
Gross profit
     12,053        414        12,467  
Research and development expenses
     2,692        8,264        10,956  
Sales and marketing expenses
     1,648        1,574        3,222  
General and administrative expenses
     1,176        1,190        2,366  
    
 
 
    
 
 
    
 
 
 
Segment operating profit (loss)
     6,537        (10,614      (4,077
    
 
 
    
 
 
    
 
 
 
Change in fair value of Forfeiture Shares
                           
Financial expenses, net
                       503  
                      
 
 
 
Loss before taxes on income
                       (3,574
                      
 
 
 
Depreciation expenses
     22        244        266  
    
 
 
    
 
 
    
 
 
 
 
20

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 11 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER
(continued):
 
 
b.
Geographic Revenues
The following table shows revenue by geography, based on the customers’ “bill to” location:
 
    
Six months ended

June 30
    
Three months ended

June 30
 
    
2022
    
2021
    
2022
    
2021
 
                             
    
U.S. dollars in thousands
 
Israel
     1,279        779        749        371  
China
     5,339        8,233        2,533        4,787  
United States
     7,238        3,834        3,681        1,301  
Hong Kong
     7,286        5,567        3,965        3,592  
Hungary
     6,399        3,051        2,486        1,630  
Japan
     5,274        3,515        3,239        2,487  
Other
     11,286        5,895        5,828        3,342  
    
 
 
    
 
 
    
 
 
    
 
 
 
       44,101        30,874        22,481        17,510  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
 
c.
Supplemental data - Major Customers:
The following tables summarize the significant customers’ (including distributors) accounts receivable and revenues as a percentage of total accounts receivable and total revenues, respectively:
 
    
June 30,

2022
   
December 31,

2021
 
              
Accounts Receivable
  
U.S. dollars in thousands
 
Customer A
     17     12
Customer B
     5     16
Customer C
     10     7
 
    
Six months

ended June 30,
   
Three months

ended June 30,
 
    
2022
   
2021
   
2022
   
2021
 
                          
Revenues
  
U.S. dollars in

thousands
   
U.S. dollars in

thousands
 
Customer D
     11     11     14     14
Customer A
     10     5     10     5
Customer E
     0     12     0     14
Customer F
     7     11     7     11
Customer G
     6     10     7     12
 
 
d.
Property and Equipment by Geography:
 
    
June 30,

2022
    
December 31,

2021
 
               
    
U.S. dollars in thousands
 
Domestic (Israel)
     2,102        2,259  
Taiwan
     157        199  
China
     159        210  
USA
     153        73  
    
 
 
    
 
 
 
    
 
2,571
 
  
 
2,741
 
 
21

Table of Contents
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
 
NOTE 12 - RELATED PARTY TRANSACTIONS
During the six months ended June 30, 2022, the Company granted 239,610 stock options, at a weighted average exercise price of $6.28 to several executive officers, and Board Of Directors (“Board”) members of the Company. In addition, during the six months ended June 30, 2022 the Company granted 491,775 RSUs to several executive officers and Board members of the Company.
The fair value of the stock options that were granted during the six months ended June 30, 2022 is $362 thousand, which is expected to be recognized over a 1-year vesting period, and the fair value of the granted RSUs is $2,603 thousand, which is expected to be recognized over a
1
-4-years vesting period.
 
 
 
 
 
22